Interleukin 4 promotes the growth of tumor-infiltrating lymphocytes cytotoxic for human autologous melanoma (Q36355725)

From Wikidata

Jump to navigation Jump to search

scientific article

edit

Language	Label	Description	Also known as
English	Interleukin 4 promotes the growth of tumor-infiltrating lymphocytes cytotoxic for human autologous melanoma	scientific article

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PMC publication ID

2189149

retrieved

13 August 2017

title

Interleukin 4 promotes the growth of tumor-infiltrating lymphocytes cytotoxic for human autologous melanoma (English)

1 reference

stated in

Europe PubMed Central

PMC publication ID

2189149

retrieved

13 August 2017

main subject

cytotoxicity

0 references

lymphocyte

0 references

interleukins

0 references

author

Steven Rosenberg

series ordinal

2

object named as

Rosenberg SA

1 reference

stated in

Europe PubMed Central

PMC publication ID

2189149

retrieved

13 August 2017

Michael T Lotze

series ordinal

3

object named as

Lotze MT

1 reference

stated in

Europe PubMed Central

PMC publication ID

2189149

retrieved

13 August 2017

author name string

Kawakami Y

series ordinal

1

1 reference

stated in

Europe PubMed Central

PMC publication ID

2189149

retrieved

13 August 2017

language of work or name

English

0 references

publication date

1 December 1988

1 reference

stated in

Europe PubMed Central

PMC publication ID

2189149

retrieved

13 August 2017

published in

Journal of Experimental Medicine

1 reference

stated in

Europe PubMed Central

PMC publication ID

2189149

retrieved

13 August 2017

volume

168

1 reference

stated in

Europe PubMed Central

PMC publication ID

2189149

retrieved

13 August 2017

issue

6

1 reference

stated in

Europe PubMed Central

PMC publication ID

2189149

retrieved

13 August 2017

page(s)

2183-2191

1 reference

stated in

Europe PubMed Central

PMC publication ID

2189149

retrieved

13 August 2017

cites work

Interleukin 4 (B cell stimulatory factor 1) can mediate the induction of lymphokine-activated killer cell activity directed against fresh tumor cells

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2189149

retrieved

30 September 2017

B-cell stimulatory factor-1/interleukin 4.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2189149

retrieved

30 September 2017

Molecular biology of interleukin 4 and interleukin 5 genes and biology of their products that stimulate B cells, T cells and hemopoietic cells

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2189149

retrieved

30 September 2017

Heterogeneity of helper/inducer T lymphocytes. I. Lymphokine production and lymphokine responsiveness

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2189149

retrieved

30 September 2017

Regulation of cytolytic cell populations from human peripheral blood by B cell stimulatory factor 1 (interleukin 4).

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2189149

retrieved

29 June 2018

Expansion of human tumor infiltrating lymphocytes for use in immunotherapy trials

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2189149

retrieved

29 June 2018

Identification of specific cytolytic immune responses against autologous tumor in humans bearing malignant melanoma.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2189149

retrieved

29 June 2018

Proliferation of T lymphocytes in response to interleukin 2 varies with their state of activation

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2189149

retrieved

29 June 2018

IL-4 inhibits IL-2-mediated induction of human lymphokine-activated killer cells, but not the generation of antigen-specific cytotoxic T lymphocytes in mixed leukocyte cultures.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2189149

retrieved

22 September 2018

Lysis of fresh and cultured autologous tumor by human lymphocytes cultured in T-cell growth factor

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/3264324

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/3264324

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recombinant interleukin 4 promotes the growth of human T cells

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/3264324

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Increased vascular permeability in organs mediated by the systemic administration of lymphokine-activated killer cells and recombinant interleukin-2 in mice

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/3264324

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunotherapy of patients with advanced cancer using tumor-infiltrating lymphocytes and recombinant interleukin-2: a pilot study

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/3264324

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A new approach to the adoptive immunotherapy of cancer with tumor-infiltrating lymphocytes

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/3264324

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

DOI

10.1084/JEM.168.6.2183

1 reference

stated in

Europe PubMed Central

PMC publication ID

2189149

retrieved

13 August 2017

PMC publication ID

2189149

1 reference

stated in

Europe PubMed Central

PMC publication ID

2189149

retrieved

13 August 2017

PubMed publication ID

3264324

1 reference

stated in

Europe PubMed Central

PMC publication ID

2189149

retrieved

13 August 2017

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36355725&oldid=1999678556"